Trial Profile
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Sotatercept (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Sponsors Celgene Corporation; Merck Sharp & Dohme
- 24 Dec 2014 New trial record